Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines.

Literature DB >> 24599377

Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines.

Abstract

In 2008 the EANM published their paediatric dosage card. In 2011 the North American consensus guidelines recommended a set of administered activities for paediatric nuclear medicine. During the EANM congress in 2012 a working group of the EANM and the SNMMI met to study the possibility of harmonizing these guidelines. The purpose of this work was to identify differences between these guidelines and suggest changes in both guidelines to achieve a level of harmonization. In addition, the new version of the EANM paediatric dosage card (version 01.02.2014) is provided.

Mesh：

Substances：
Radiopharmaceuticals

Year: 2014 PMID： 24599377 DOI： 10.1007/s00259-014-2731-9

Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236

11 in total

1. An approach for balancing diagnostic image quality with cancer risk: application to pediatric diagnostic imaging of 99mTc-dimercaptosuccinic acid.

Authors: George Sgouros; Eric C Frey; Wesley E Bolch; Michael B Wayson; Andres F Abadia; S Ted Treves
Journal: J Nucl Med Date: 2011-12 Impact factor: 10.057

2. The new EANM paediatric dosage card.

Authors: M Lassmann; L Biassoni; M Monsieurs; C Franzius; F Jacobs
Journal: Eur J Nucl Med Mol Imaging Date: 2007-04-04 Impact factor: 9.236

3. The new EANM paediatric dosage card: additional notes with respect to F-18.

Authors: M Lassmann; L Biassoni; M Monsieurs; C Franzius
Journal: Eur J Nucl Med Mol Imaging Date: 2008-06-24 Impact factor: 9.236

4. Pediatric radiopharmaceutical administered doses: 2010 North American consensus guidelines.

Authors: Michael J Gelfand; Marguerite T Parisi; S Ted Treves
Journal: J Nucl Med Date: 2011-01-13 Impact factor: 10.057

5. Evaluation of optimal acquisition duration or injected activity for pediatric 18F-FDG PET/CT.

Authors: Adam M Alessio; Marla Sammer; Grace S Phillips; Vivek Manchanda; Brandt C Mohr; Marguerite T Parisi
Journal: J Nucl Med Date: 2011-06-16 Impact factor: 10.057

6. Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53).

Authors:
Journal: Ann ICRP Date: 1998

7. Improved dose regimen in pediatric PET.

Authors: Roberto Accorsi; Joel S Karp; Suleman Surti
Journal: J Nucl Med Date: 2010-01-15 Impact factor: 10.057

Review 8. Dosimetry of FDG PET/CT and other molecular imaging applications in pediatric patients.

Authors: Michael J Gelfand
Journal: Pediatr Radiol Date: 2008-12-16

9. Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007.

Authors:
Journal: Ann ICRP Date: 2008

Review 10. Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review.

Authors: Uta Eberlein; Jörn Hendrik Bröer; Charlot Vandevoorde; Paula Santos; Manuel Bardiès; Klaus Bacher; Dietmar Nosske; Michael Lassmann
Journal: Eur J Nucl Med Mol Imaging Date: 2011-08-30 Impact factor: 9.236

22 in total

1. Recommended administered activities for (68)Ga-labelled peptides in paediatric nuclear medicine.

Authors: J Soares Machado; S Beykan; K Herrmann; M Lassmann
Journal: Eur J Nucl Med Mol Imaging Date: 2016-01-09 Impact factor: 9.236

2. Guidelines on nuclear medicine imaging in neuroblastoma.

Authors: Zvi Bar-Sever; Lorenzo Biassoni; Barry Shulkin; Grace Kong; Michael S Hofman; Egesta Lopci; Irina Manea; Jacek Koziorowski; Rita Castellani; Ariane Boubaker; Bieke Lambert; Thomas Pfluger; Helen Nadel; Susan Sharp; Francesco Giammarile
Journal: Eur J Nucl Med Mol Imaging Date: 2018-10 Impact factor: 9.236

3. New EANM paediatric dosage card: optimization of F-18 FDG-administered activities.

Authors: Gilles Metrard; Hélène Besse; Diane Darsin-Bettinger; Sofiane Mouzoune; Sabine Gauvain
Journal: Eur J Nucl Med Mol Imaging Date: 2014-06-04 Impact factor: 9.236

4. Pediatric Radiopharmaceutical Administration: harmonization of the 2007 EANM Paediatric Dosage Card (Version 1.5.2008) and the 2010 North American Consensus guideline.

Authors: Michael Lassmann; S Ted Treves
Journal: Eur J Nucl Med Mol Imaging Date: 2014-08 Impact factor: 9.236

5. Standardization of administered activities in paediatric nuclear medicine: the EANM perspective.

Authors: Michael Lassmann; Uta Eberlein; Egesta Lopci; Arturo Chiti
Journal: Eur J Nucl Med Mol Imaging Date: 2016-08-06 Impact factor: 9.236

6. Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012.

Authors: Boel Johnsen; Kristine Eldevik Fasmer; Kjetil Boye; Karen Rosendahl; Clement Trovik; Martin Biermann; Stein Magnus Aukland
Journal: Pediatr Radiol Date: 2016-11-04

Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines.

1. An approach for balancing diagnostic image quality with cancer risk: application to pediatric diagnostic imaging of 99mTc-dimercaptosuccinic acid.

2. The new EANM paediatric dosage card.

3. The new EANM paediatric dosage card: additional notes with respect to F-18.

4. Pediatric radiopharmaceutical administered doses: 2010 North American consensus guidelines.

5. Evaluation of optimal acquisition duration or injected activity for pediatric 18F-FDG PET/CT.

6. Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53).

7. Improved dose regimen in pediatric PET.

Review 8. Dosimetry of FDG PET/CT and other molecular imaging applications in pediatric patients.

9. Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007.

Review 10. Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review.

1. Recommended administered activities for (68)Ga-labelled peptides in paediatric nuclear medicine.

2. Guidelines on nuclear medicine imaging in neuroblastoma.

3. New EANM paediatric dosage card: optimization of F-18 FDG-administered activities.

4. Pediatric Radiopharmaceutical Administration: harmonization of the 2007 EANM Paediatric Dosage Card (Version 1.5.2008) and the 2010 North American Consensus guideline.

5. Standardization of administered activities in paediatric nuclear medicine: the EANM perspective.

6. Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012.

7. An Australian local diagnostic reference level for paediatric whole-body ¹⁸F-FDG PET/CT.

8. Ultra low-dose VCUG in children using a modern flat detectorunit.

9. The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children.

Review 10. Clinical application of ¹⁸F-DOPA PET/TC in pediatric patients.

Review 8. Dosimetry of FDG PET/CT and other molecular imaging applications in pediatric patients.

Review 10. Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review.

Review 10. Clinical application of 18F-DOPA PET/TC in pediatric patients.

Review 10. Clinical application of ¹⁸F-DOPA PET/TC in pediatric patients.